Comprising more than 80 leading institutes EATRIS provides state of the art technologies and expertise required to advance the development of innovative therapies, vaccines and diagnostics. They leverage their state-of-the-art facilities and knowledge by creating synergies and sharing best practices.
Participating institutes are selected and continuously monitored on the basis of the available infrastructure, expertise and quality standards which comply with current European pharmaceutical regulations, laws and guidelines. As an EATRIS institute, there must be a clear focus on translational research, providing access to multi-disciplinary translational environments, resources, and clinical cohorts.
These institutions and their translational researchers provide a new development pathway, open to researchers and companies in need of support for advancing their biomedical innovations.